Skip Navigation Links.
American Journal of Clinical Medicine Research. 2017, 5(4), 59-63
DOI: 10.12691/AJCMR-5-4-5
Case Report

Rising Mean Platelet Volume (MPV) Heralding Platelets Recovery in Dengue?

Ajay Khandal1, and D. Raghuraman2

1Department of Medicine, Prathima Institute of Medical Sciences, Karimnagar, India

2Chairman Institutional ethics committee, Prathima Institute of Medical Sciences, Karimnagar, India

Pub. Date: July 20, 2017
Full Text PDF

Cite this paper

Ajay Khandal and D. Raghuraman. Rising Mean Platelet Volume (MPV) Heralding Platelets Recovery in Dengue?. American Journal of Clinical Medicine Research. 2017; 5(4):59-63. doi: 10.12691/AJCMR-5-4-5

Abstract

Infectious diseases including Dengue illness remains the commonest cause of hospitalization in Indian settings. It is a significant global public health problem, with 2.5 billion world's population at risk and an estimated 50 to 390 million annual infections. Clinically, dengue illness manifestation varies from asymptomatic state to severe symptomatic disease. Symptomatic disease events in turn range from self-limiting dengue fever (DF) to severe dengue. Severe dengue, manifests as; dengue hemorrhagic fever (DHF), hypovolemic shock—dengue shock syndrome (DSS) or severe organ impairment. Thrombocytopenia is a common element to both dengue fever and severe dengue; and clinicians, unfortunately, tend to ‘react' to thrombocytopenia with platelet transfusions at predetermined platelet thresholds. Readily available lab parameters to guide the clinician of impending platelet recovery is needed, one such parameter gaining recent interest is Platelet Indices (PIs): mean platelet volume (MPV) and platelet distribution width (PDW). Serially observing mean platelet volume along with Platelets might be valuable, with a rising trend in MPV suggesting platelet and patient recovery.

Keywords

dengue, thrombocytopenia, dengue cost of hospitalization, thrombocytopenia mechanisms

Copyright

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References

[1]  Government of India (2015) Key Indicators of Social Consumption in India Health. NSS 71Round. January - June 2014. Ministry of Statistics and Programme Implementation. National Sample Survey Office.
 
[2]  Shepard DS, Halasa YA, Tyagi BK, et al. Economic and Disease Burden of Dengue Illness in India. The American Journal of Tropical Medicine and Hygiene. 2014; 91(6): 1235-1242.
 
[3]  Ayalew et al.: How to Interpret and Pursue an Abnormal Complete Blood Cell Count in Adults, Mayo Clin Proc. 2005;80(7): 923-936.
 
[4]  Farias, M., Schunck, E., Dal Bó, S., et al. (2009). Definition of reference ranges for the platelet distribution width (PDW): a local need. Clinical Chemistry and Laboratory Medicine, 48(2), pp. 255-257.
 
[5]  Lippi G, Pavesi F, Pipitone S. Evaluation of mean plate- let volume with four haematological analyzers: har- monization is still an unresolved issue. Blood Coagul Fi- brinolysis 2015; 26: 235-7.
 
[6]  Larsen SB, Grove EL, Hvas AM, Kristensen SD. Platelet turnover in stable coronary artery disease-influence of thrombopoietin and low-grade inflammation. PLoS One. 2014; 9: e85566.
 
[7]  Ates I, Bulut M, Ozkayar N, Dede F. Association between high platelet indices and proteinuria in patients with hypertension. Ann Lab Med. 2015; 35: 630-4.
 
[8]  Öztürk ZA, Dag MS, Kuyumcu ME, Cam H, Yesil Y, Yilmaz N, et al. Could platelet indices be new biomarkers for inflammatory bowel diseases? Eur Rev Med Pharmacol Sci. 2013; 17: 334-41.
 
[9]  Budak YU, Polat M, Huysal K. The use of platelet indices, plateletcrit, mean platelet volume and platelet distribution width in emergency non-traumatic abdominal surgery: a systematic review. Biochemia Medica. 2016; 26(2): 178-193.
 
[10]  Murat Afyon et al.. Could mean platelet volume be a useful marker for infectious diseases? a review of literature, medscience. 2016. 05. 8460.
 
[11]  Katti TV, Mhetre SC, Annigeri C. How far are the platelet indices mirror image of mechanism of thrombocytopenia-mystery still remains? Int J Adv Med 2014; 1: 200-5.
 
[12]  Bashir AB, Saeed OK, Mohammed BA, Ageep AK. Role of Platelet Indices in Patients with Dengue Infection in Red Sea State, Sudan. IJSR. 2015; 4(1): l573-6.
 
[13]  Dewi YP. Mean Platelet Volume (MPV): Potential Predictor of Disease Severity in Dengue infection. In proceeding of: International Dengue Symposium. 2013 conference paper.
 
[14]  Economic and disease burden of dengue in Southeast Asia. Shepard DS, Undurraga EA, Halasa YA. PLoS Negl Trop Dis. 2013; 7(2): e2055.
 
[15]  National Vector Borne Disease Control Programme. Dengue Cases and Deaths in the Country since 2007. Ministry of Health and Family Welfare, Directorate General of Health Services; 2013.
 
[16]  Garg P, Nagpal J, Khairnar P, Seneviratne SL. Economic burden of dengue infections in India. Trans R Soc Trop Med Hyg. 2008; 102: 570-7.
 
[17]  Ahluwalia G, Sharma SK. Dengue: Current Trends and Challenges - An Indian Perspective. J Assoc Physicians India. 2004; 52: 561-3.
 
[18]  Dadu, T., Sehgal, K., Joshi, M. and Khodaiji, S. (2014), Evaluation of the immature platelet fraction as an indicator of platelet recovery in dengue patients. Int. Jnl. Lab. Hem., 36: 499-504.
 
[19]  Rajnish Joshi, John M. Colford Jr., Arthur L. Reingold, and Shriprakash Kalantri* Nonmalarial Acute Undifferentiated Fever in a Rural Hospital in Central India: Diagnostic Uncertainty and Overtreatment with Antimalarial Agents Am. J. Trop. Med. Hyg., 78(3), 2008, pp. 393-399.
 
[20]  Araya Gebreyesus wasihun, Letemichael Negash Wlekidan, Senay Aregawi Gebremariam, Abadi Luel Welderufael, Saravanan Muthupandian, Tadesse Dejenie Haile, Tsehaye Asmelash Dejene, Diagnosis and Treatment of Typhoid Fever and Associated Prevailing Drug Resistance in Northern Ethiopia, International Journal of Infectious Diseases, Volume 35, 2015, Pages 96-102.
 
[21]  Guidelines for the treatment of malaria – 3rd edition. World Health Organization 2015.
 
[22]  Haanshuus CG, Chandy S, Manoharan A, Vivek R, Mathai D, Xena D, et al. (2016) A High Malaria Prevalence Identified by PCR among Patients with Acute Undifferentiated Fever in India. PLoS ONE 11(7): e0158816.
 
[23]  Handbook for clinical management of dengue. World Health Organization 2012.
 
[24]  Khandal A. MPV and DENGUE. IJIRAS.Volume 4 Issue 6, June 2017.
 
[25]  Runi Datta. The World of Quacks: A Parallel Health Care System in Rural West Bengal IOSR Journal Of Humanities And Social Science (IOSR-JHSS).
 
[26]  Eldor A, Avitzour M, OR R, Hanna R, Penchas S. Prediction of haemorrhagic diathesis in thrombocytopenia by mean platelet volume. Br Med J. 1982; 285(6339): 397-400.
 
[27]  Demirin H, Ozhan H, Ucgun T, Celer A, Bulur S, Cil H, et al. Normal range of mean platelet volume in healthy subjects: insight from a large epidemiologic study. Thromb Res. 2011; 128: 358-60.
 
[28]  Sachdev R, Tiwari AK, Goel S, Raina V, Sethi M. Establishing biological reference intervals for novel platelet parameters (immature platelet fraction, high immature platelet fraction, platelet distribution width, platelet large cell ratio, platelet-X, plateletcrit, and platelet distribution width) and their correlations among each other. Indian J Pathol Microbiol. 2014; 57: 231-5.
 
[29]  Maluf CB, Barreto SM, Vidigal PG. Standardization and reference intervals of platelet volume indices: Insight from the Brazilian longitudinal study of adult health (ELSA-BRASIL). Platelets. 2015; 26: 413-20.
 
[30]  Lippi G, Pavesi F, Pipitone S. Evaluation of mean platelet volume with four haematological analyzers: harmonization is still an unresolved issue. Blood Coagul Fibrinolysis. 2015; 26: 235-7.
 
[31]  Navya BN, Patil S, Kariappa TM. Role of platelet parameters in dengue positive cases - an observational study. Int J Health Sci Res. 2016; 6(6):74-78.
 
[32]  Prakash GM, Anikethana G V. Use of mean platelet volume and platelet distribution width in predicting trend in platelet count and bleeding risks in patients of dengue fever. Int J Adv Med 2016; 3: 611-3.
 
[33]  Wiwanitkit V. Mean platelet volume in the patients with dengue hemorrhagic fever, Platelets 2004;15(3):185.
 
[34]  Elzinandes Leal de Azeredo, Robson Q. Monteiro, and Luzia Maria de-Oliveira Pinto, “Thrombocytopenia in Dengue: Interrelationship between Virus and the Imbalance between Coagulation and Fibrinolysis and Inflammatory Mediators,” Mediators of Inflammation, vol. 2015, Article ID 313842, 16 pages, 2015.
 
[35]  KRISHNAMURTHY, Vani; RAJESHAKAR, Rajalakshmi; DORESWAMY, Srinivasa Murthy. Thrombocytopenia in Dengue illness: Destruction, Suppression and Composite platelet index: A Retrospective study. Annals of Pathology and Laboratory Medicine, [S.l.], v. 3, n. 5, p. A465-470, nov. 2016.
 
[36]  Khaleed JK, Abeer Anwer AA, Maysem Alwash AA. Platelet indices and their relations to platelet count in hypoproductive and hyper-destructive Thrombocytopenia. Karbala J. Med. 2014; 7: 1952-8.
 
[37]  David C. Lye, Vernon J. Lee, Yan Sun, Yee Sin Leo; Lack of Efficacy of Prophylactic Platelet Transfusion for Severe Thrombocytopenia in Adults with Acute Uncomplicated Dengue Infection. Clin Infect Dis 2009; 48 (9): 1262-1265.
 
[38]  Preventive transfusion in dengue shock syndrome–is it necessary? Lum, Lucy Chai See et al.The Journal of Pediatrics , Volume 143 , Issue 5 , 682-684.
 
[39]  Rossi, F. C. et al., Transfusion, A novel association of acquired ADAMTS13 inhibitor and acute dengue virus infection 2010, 50(1), 208-212.
 
[40]  Djamiatun K, van der Ven AJAM, de Groot PG, Faradz SMH, Hapsari D, Dolmans WMV, et al. (2012). Severe Dengue Is Associated with Consumption of von Willebrand Factor and Its Cleaving Enzyme ADAMTS-13. PLoS Negl Trop Dis 6(5): e1628.
 
[41]  Sellahewa, K. H., Samaraweera, N., Thu- sita, K. P. and Fernando, J. L., Is fresh frozen plasma effective for thrombocytopenia in adults with dengue fever? A prospective randomised double blind controlled study. Ceylon Med. J., 2008, 53(2), 36-40.
 
[42]  Castro RA, Castro JA, Barez MY, Frias MV, Dixit J, Genereux M. Thrombocytopenia associated with dengue hemorrhagic fever responds to intravenous administration of anti – D (Rh(O) – D) immune globulin. Am J Trop Med Hyg. 2007;76(4):737-742.
 
[43]  Pannu AK, Bhalla A, Singhal M, Suri V, Sha q N, Varma S. Safety and ef cacy of a single dose of Anti-D (WinRho®) in severe thrombocytopenia secondary to dengue virus infection. Indian J Crit Care Med 2017; 21: 80-4.